<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00663104</url>
  </required_header>
  <id_info>
    <org_study_id>OFZ-Trace</org_study_id>
    <nct_id>NCT00663104</nct_id>
  </id_info>
  <brief_title>Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause</brief_title>
  <official_title>Effect of Exercise and Exercise + Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siemens-Betriebskrankenkasse</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the effect of a progressive, periodized exercise training
      designed to impact bone, CHD-risk-factors and menopausal complaints versus the combined
      effect of exercise and &quot;phytoestrogen&quot; (cimicifuga racemosa; CR). After randomization, 84
      females 1-3 year postmenopausal with no medication or illness affecting bone metabolism
      exercise over 12 months (EG; 42 with, 42 without CR), 42 women serve as wellness-control.
      Three group training sessions/week will be performed in the EG. Both groups will be
      individually supplemented with calcium and Vit-D (cholecalciferol).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>baseline, 12 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>baseline, 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lipids, glucose</measure>
    <time_frame>baseline, 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>baseline, 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10 year CHD-risk</measure>
    <time_frame>baseline, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>menopausal complaints</measure>
    <time_frame>baseline, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Bone Diseases</condition>
  <condition>Metabolic Syndrome X</condition>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise (3 sessions/week)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise and &quot;phytoestrogen&quot; (cimicifuga racemosa)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>wellness control, placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>exercise: 3 joint sessions/week for 12 months</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise + cimicifuga racemosa</intervention_name>
    <description>exercise: 3 sessions/week for 12 months,cimicifuga racemosa (40 mg/d)</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>wellness control, placebo</intervention_name>
    <description>2x10 weeks with 1 session/week of low volume, low intensity wellness training over 12 months, placebo</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1-3 years early postmenopausal

          -  Caucasian race

        Exclusion Criteria:

          -  CHD-diseases

          -  thrombosis, embolism

          -  fractures at lumbar spine or hip

          -  secondary osteoporosis

          -  hyperparathyroidism

          -  medication, diseases with impact on muscle or bone

          -  cancer and hormone derived malign diseases

          -  weight reduction of &gt; 5 kg during the last 6 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bebenek, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolfgang Kemmler, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Willi A Kalender, Professor, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Medical Physics</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kemmler W, Lauber D, Weineck J, Hensen J, Kalender W, Engelke K. Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS). Arch Intern Med. 2004 May 24;164(10):1084-91.</citation>
    <PMID>15159265</PMID>
  </reference>
  <reference>
    <citation>von Stengel S, Kemmler W, Kalender WA, Engelke K, Lauber D. Differential effects of strength versus power training on bone mineral density in postmenopausal women: a 2-year longitudinal study. Br J Sports Med. 2007 Oct;41(10):649-55; discussion 655. Epub 2007 Jun 5. Erratum in: Br J Sports Med. 2007 Dec;41(12):926.</citation>
    <PMID>17550916</PMID>
  </reference>
  <reference>
    <citation>Kemmler W, von Stengel S, Weineck J, Lauber D, Kalender W, Engelke K. Exercise effects on menopausal risk factors of early postmenopausal women: 3-yr Erlangen fitness osteoporosis prevention study results. Med Sci Sports Exerc. 2005 Feb;37(2):194-203.</citation>
    <PMID>15692313</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2008</study_first_submitted>
  <study_first_submitted_qc>April 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2008</study_first_posted>
  <last_update_submitted>May 27, 2015</last_update_submitted>
  <last_update_submitted_qc>May 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Wolfgang Kemmler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>early menopause</keyword>
  <keyword>exercise</keyword>
  <keyword>phytoestrogen</keyword>
  <keyword>bone</keyword>
  <keyword>CHD-risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Bone Diseases</mesh_term>
    <mesh_term>Menopause, Premature</mesh_term>
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phytoestrogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

